Editas Medicine, Inc. (EDIT)

2.425 +0.08 (+3.19%) USD  |  NASDAQ  |  Oct 19, 16:00
2.425 0.00 (0.00%) After-Hours: 16:50
More

Editas Medicine Cash from Operations (Annual) : -165.24M for Dec. 31, 2025

Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2015. Start Trial.
Date Value
December 31, 2025 -165.24M
December 31, 2024 -210.28M
December 31, 2023 -132.18M
December 31, 2022 -177.35M
December 31, 2021 -163.80M
December 31, 2020 -179.84M
Date Value
December 31, 2019 -40.67M
December 31, 2018 -45.71M
December 31, 2017 -9.417M
December 31, 2016 -50.25M
December 31, 2015 -5.403M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Recursion Pharmaceuticals, Inc. -371.81M
Geron Corp. -111.04M
Halozyme Therapeutics, Inc. 651.56M
Novavax, Inc. -244.64M
AVITA Medical, Inc. -31.20M